Macroscopic tumor size as an independent prognostic factor for stage II/III gastric cancer patients who underwent D2 gastrectomy followed by adjuvant chemotherapy with S-1

Author： Aoyama Toru  

Publisher： Springer Publishing Company

ISSN： 1436-3291

Source： Gastric Cancer, Vol.14, Iss.3, 2011-08, pp. : 274-278

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tolerability of adjuvant chemotherapy with S-1 after curative resection in patients with stage II/III gastric cancer

By                      

Oncology Letters, Vol. 4, Iss. 5, 2012-01 ,pp. : 1135-1139

Spandidos Publications

Access to resources Recommend Favorite

Three-year outcomes of a phase II study of adjuvant chemotherapy with S-1 plus docetaxel for stage III gastric cancer after curative D2 gastrectomy

By Fujitani Kazumasa   Tamura Shigeyuki   Kimura Yutaka   Tsuji Takeshi   Matsuyama Jin   Iijima Shohei   Imamura Hiroshi   Inoue Kentaro   Kobayashi Kenji   Kurokawa Yukinori   Shimokawa Toshio   Tsujinaka Toshimasa   Furukawa Hiroshi  

Gastric Cancer, Vol. 17, Iss. 2, 2014-04 ,pp. : 348-353

Springer Publishing Company

Access to resources Recommend Favorite

Gastrectomy as a secondary surgery for stage IV gastric cancer patients who underwent S-1-based chemotherapy: a multi-institute retrospective study

By Kanda Tatsuo   Yajima Kazuhito   Kosugi Shin-ichi   Ishikawa Takashi   Ajioka Yoichi   Hatakeyama Katsuyoshi  

Gastric Cancer, Vol. 15, Iss. 3, 2012-07 ,pp. : 235-244

Springer Publishing Company

Access to resources Recommend Favorite

Survival analysis of adjuvant chemotherapy with S-1 plus cisplatin for stage III gastric cancer

By Takahari Daisuke   Hamaguchi Tetsuya   Yoshimura Kenichi   Katai Hitoshi   Ito Seiji   Fuse Nozomu   Konishi Masaru   Yasui Hirofumi   Terashima Masanori   Goto Masahiro   Tanigawa Nobuhiko   Shirao Kuniaki   Sano Takeshi   Sasako Mitsuru  

Gastric Cancer, Vol. 17, Iss. 2, 2014-04 ,pp. : 383-386

Springer Publishing Company

Access to resources Recommend Favorite

Phase II Trial of Neoadjuvant Chemotherapy with Docetaxel Followed by Epirubicin in Stage II/III Breast Cancer

By Ramaswamy Bhuvaneswari   Povoski Steven   Rhoades Chris   Allen Joan   Hauger Marsha   Young Donn   Burak William   Farrar William   Yee Lisa   Kendra Kari   Somasundaram Sivagurunathan   Orlowski Robert   Shapiro Charles  

Breast Cancer Research and Treatment, Vol. 93, Iss. 1, 2005-09 ,pp. : 67-74

Springer Publishing Company

Access to resources Recommend Favorite